Omer Faruk Hatipoglu

Dr. Omer Faruk Hatipoglu

Kindai University, Ōsaka, Japan
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
OHOmer Faruk Hatipoglu
Omer Faruk Hatipoglu
TNTakashi Nishinaka
Takashi Nishinaka
MNMasahiro Nishibori
Masahiro Nishibori
MWMasahiro Watanabe
Masahiro Watanabe
TTTakao Toyomura
Takao Toyomura
HTHideo Takahashi
Hideo Takahashi
Histamine is a well-known inflammatory mediator, but how histamine induces angiogenesis remains poorly understood. In the present study, we demonstrated a dose-dependent dynamic tube formation in the human endothelial cell line EA.hy926 in the presence of histamine that was completely blocked by histamine H1 receptor (H1R) and protein kinase C (PKC) inhibitors. However, histamine H2, H3, and H4 receptor inhibitors did not inhibit tube formation, suggesting that H1R-PKC signaling is involved in histamine-induced tube formation. Moreover, we found an H1-specific induction of vascular endothelial growth factor (VEGF) expression. Inhibition of VEGF receptor 2 (VEGFR2) suppressed the histamine-induced tube formation, indicating that VEGF is downstream of histamine signaling. Additionally, we demonstrated that histamine stimulation induces the expression of critical regulators of angiogenesis such as matrix metalloproteinase (MMP)-9 and MMP-14 metalloproteases, as histamine-induced tube formation is blocked by MMP inhibitors. In summary, our study indicates that histamine can activate the H1R in human endothelial cells and thereby promote tube formation through the PKC, MMP, and VEGF signaling pathways.

Verified
Journal Article
Open access
PDF file
TOTakashi Ohtsuki
Takashi Ohtsuki
OHOmer Faruk Hatipoglu
Omer Faruk Hatipoglu
KAKeiichi Asano
Keiichi Asano
JIJunko Inagaki
Junko Inagaki
KNKeiichiro Nishida
Keiichiro Nishida
SHSatoshi Hirohata
Satoshi Hirohata
In patients with osteoarthritis (OA), there is a decrease in both the concentration and molecular size of hyaluronan (HA) in the synovial fluid and cartilage. Cell migration-inducing hyaluronidase 1 (CEMIP), also known as hyaluronan (HA)-binding protein involved in HA depolymerization (HYBID), was recently reported as an HA depolymerization-related molecule expressed in the cartilage of patients with OA. However, the underlying mechanism of CEMIP regulation is not well understood. We found that CEMIP expression was transiently increased by interleukine-1β (IL-1β) stimulation in chondrocytic cells. We also observed that ERK activation and NF-κB nuclear translocation were involved in the induction of CEMIP by IL-1β. In addition, both administration of HA and mechanical strain attenuated the CEMIP induction in IL-1β-stimulated chondrocytes. In conclusion, we clarified the regulatory mechanism of CEMIP in chondrocytes by inflammatory cytokines and suggested the potential involvement in osteoarthritis development.

1 November 2021 in Experimental Cell Research
Verified
Journal Article
Closed access
YYYui Yamazaki
Yui Yamazaki
HWHidenori Wake
Hidenori Wake
TNTakashi Nishinaka
Takashi Nishinaka
OHOmer Faruk Hatipoglu
Omer Faruk Hatipoglu
KLKeyue Liu
Keyue Liu
HTHideo Takahashi
Hideo Takahashi

25 January 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAtsuhiro Kitaura
Atsuhiro Kitaura
TNTakashi Nishinaka
Takashi Nishinaka
SHShinichi Hamasaki
Shinichi Hamasaki
OHOmer Faruk Hatipoglu
Omer Faruk Hatipoglu
HWHidenori Wake
Hidenori Wake
HTHideo Takahashi
Hideo Takahashi
Hyperglycaemia provides a suitable environment for infections and the mechanisms of glucose toxicity include the formation of advanced glycation end-products (AGEs), which comprise non-enzymatically glycosylated proteins, lipids, and nucleic acid amino groups. Among AGE-associated phenotypes, glycolaldehyde-derived toxic AGE (AGE-3) is involved in the pathogenesis of diabetic complications. Internalisation of endotoxin by various cell types contributes to innate immune responses against bacterial infection. An endotoxin derived from Gram-negative bacteria, lipopolysaccharide (LPS), was reported to enhance its own uptake by RAW264.7 mouse macrophage-like cells, and an LPS binding protein, CD14, was involved in the LPS uptake. The LPS uptake induced the activation of RAW264.7 leading to the production of chemokine CXC motif ligand (CXCL) 10, which promotes T helper cell type 1 responses. Previously, we reported that AGE-3 was internalised into RAW264.7 cells through scavenger receptor-1 Class A. We hypothesized that AGEs uptake interrupt LPS uptake and impair innate immune response to LPS in RAW264.7 cells. In the present study, we found that AGE-3 attenuated CD14 expression, LPS uptake, and CXCL10 production, which was concentration-dependent, whereas LPS did not affect AGE uptake. AGEs were reported to stimulate the receptor for AGEs and Toll-like receptor 4, which cause inflammatory reactions. We found that inhibitors for RAGE, but not Toll-like receptor 4, restored the AGE-induced suppression of CD14 expression, LPS uptake, and CXCL10 production. These results indicate that the receptor for the AGE-initiated pathway partially impairs the immune response in diabetes patients.

Verified
Journal Article
Open access
PDF file
JIJunko Inagaki
Junko Inagaki
NANakano Airi
Nakano Airi
OHOmer Faruk Hatipoglu
Omer Faruk Hatipoglu
YOYuka Ooka
Yuka Ooka
YTYurina Tani
Yurina Tani
SHSatoshi Hirohata
Satoshi Hirohata
Osteoarthritis is a progressive disease characterized by cartilage destruction in the joints. Matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) play key roles in osteoarthritis progression. In this study, we screened a chemical compound library to identify new drug candidates that target MMP and ADAMTS using a cytokine-stimulated OUMS-27 chondrosarcoma cells. By screening PCR-based mRNA expression, we selected 2-(8-methoxy-2-methyl-4-oxoquinolin-1(4H)-yl)-N-(3-methoxyphenyl) acetamide as a potential candidate. We found that 2-(8-methoxy-2-methyl-4-oxoquinolin-1(4H)-yl)-N-(3-methoxyphenyl) acetamide attenuated IL-1β-induced MMP13 mRNA expression in a dose-dependent manner, without causing serious cytotoxicity. Signaling pathway analysis revealed that 2-(8-methoxy-2-methyl-4-oxoquinolin-1(4H)-yl)-N-(3-methoxyphenyl) acetamide attenuated ERK- and p-38-phosphorylation as well as JNK phosphorylation. We then examined the additive effect of 2-(8-methoxy-2-methyl-4-oxoquinolin-1(4H)-yl)-N-(3-methoxyphenyl) acetamide in combination with low-dose betamethasone on IL-1β-stimulated cells. Combined treatment with 2-(8-methoxy-2-methyl-4-oxoquinolin-1(4H)-yl)-N-(3-methoxyphenyl) acetamide and betamethasone significantly attenuated MMP13 and ADAMTS9 mRNA expression. In conclusion, we identified a potential compound of interest that may help attenuate matrix-degrading enzymes in the early osteoarthritis-affected joints.

30 December 2012 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
Mehmet GunduzMehmet Gunduz
Mehmet Gunduz
EGEsra Gunduz
Esra Gunduz
LBLevent Beder
Levent Beder
DPDavut Pehlivan
Davut Pehlivan
OHOmer Faruk Hatipoglu
Omer Faruk Hatipoglu
RGReidar Grenman
Reidar Grenman